Rubi, Spain

David Mauleon Casellas

This inventor holds 2 USPTO granted patents. Top assignee: Laboratorios Menarini S.a.. Active years: 1996-1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Mauleon Casellas. Retrieved from https://idiyas.com/inventor/david-mauleon-casellas

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 1996-1999

Loading Chart...
2 patents (USPTO):Explore Patents

Title: David Mauleon Casellas: Innovator in Pharmaceutical Chemistry

Introduction

David Mauleon Casellas is a notable inventor based in Rubi, Spain. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with therapeutic applications. With a total of 2 patents to his name, his work has garnered attention in the scientific community.

Latest Patents

Among his latest patents, David has developed benzopyran derivatives that exhibit leukotriene-antagonistic action. Additionally, he has worked on an arylpropionic derivative, which includes a process for its preparation and use. These innovations highlight his commitment to advancing medical science and improving treatment options.

Career Highlights

David is currently employed at Laboratorios Menarini S.A., a company known for its dedication to research and development in the pharmaceutical sector. His role at the company allows him to apply his expertise in creating effective therapeutic agents.

Collaborations

Throughout his career, David has collaborated with esteemed colleagues, including Germano Carganico and M. Luisa Garcia Perez. These partnerships have contributed to the success of his projects and the advancement of their shared goals in pharmaceutical research.

Conclusion

David Mauleon Casellas stands out as an innovative inventor in the pharmaceutical industry. His contributions through patents and collaborations reflect his dedication to improving healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…